Skip to main content
SpringerLink
Log in

Cytotoxic Effect of Prodigiosin, Natural Red Pigment, Isolated from Serratia marcescens UFPEDA 398

  • Original research article
  • Published:
Indian Journal of Microbiology Aims and scope Submit manuscript

Abstract

Prodigiosin is a secondary metabolite, with red pigmentation, produced by Serratia marcescens. Red pigment is a natural alkaloid whose chemical structure has three pyrrole rings. Prodigiosin has been described for several biological activities, including antitumor, inducing apotosis in T and B lymphocytes. This work aimed to evaluate the cytotoxic activity of prodigiosin in NCHI-292, HEp-2, MCF-7 and HL-60 tumor cell lines. The red pigment was isolated from Serratia marcescens UFPEDA 398 biomass whose fractions were previously separated by column chromatography, purified, identified and further characterized by GC–MS and compared with the computerized library of m/z values. The pigment corresponded to prodigiosin with maximum absorption at 534 nm, molecular weight 323 and structural formula C20H25N3O. During the prodigiosin purification process a purple absorbance fraction at 272.65 nm was also observed. Significant cytotoxic effects of prodigiosin were evidenced for NCHI-292, Hep-2, MCF-7 and HL-60 tumor cell lines. The isolated purple fraction had no cytotoxic effect (IC50 11.3 µg/mL) when compared to prodigiosin (IC50 3.4 µg/mL) for the tumor cell lines studied. The MCF-7 strain was slightly more pigment resistant (IC50 5.1 µg/mL). Therefore, further studies will be needed to elucidate the antitumor mechanisms of prodigiosin action against tumor strains from flow cytometry tests. However, although these data are preliminary, it was evidenced that prodigiosin showed cytotoxic activity in tumor cell lines suggesting promising antitumor properties. In this sense, future studies on the cytotoxic and genotoxic effects of prodigiosin produced by S. marcecsens UFPEDA 398 are suggested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Cerdeno AM, Bibb MJ, Charlis GL (2001) Analysis of the prodiginine biosynthesis gene cluster of Streptomyces coelicolor A3 (2): new mechanisms for chain initiation and termination in modular multienzymes. Chem Biol 8:817–829

    Article  CAS  Google Scholar 

  2. Guryanov DI, Karamova NS, Yusupova DV, Gnezdilov OI, Koshkarova AL (2013) Bacterial pigment prodigiosin and its genotoxic effect. Russ J Bioorg Chem 39:106–111

    Article  CAS  Google Scholar 

  3. Davaraj N, Dharumaduari D, Noorudin T, Annamalai P (2009) Production of prodigiosin from Serratia marcescens and its cytotoxicity activity. J Pharm Res 2:590–593

    Google Scholar 

  4. Jeong H, Yim H, Lee C, Choi H, Park Y, Yoon S, Hur G, Kang H, Kim D, Lee H, Park K, Park S, Lee K, Kim J (2005) Genomic blueprint of Hahella chejuensis, a marine microbe producing an algicidal agent. Nucleic Acids Res 33:7066–7073

    Article  CAS  Google Scholar 

  5. Giri AV, Anandkumar N, Muthukumaran G, Pennathur G (2004) A novel medium for the enhanced cell growth and production of prodigiosin from Serratia marcescens isolated from soil. BMC Microbiol 4:11

    Article  Google Scholar 

  6. Bennett JW, Bentley R (2000) Seeing red: the story of prodigiosin. Adv Appl Microbiol 47:1–32

    Article  CAS  Google Scholar 

  7. Harris AKP, Williamnson NR, Slater H, Cox A, Abbasi S, Fouds I, Simonsen H, Fj Leeper, Salmond GPC (2004) The Serratia gene cluster encoding biosynthesis of the red antibiotic, prodigiosin, shows species- and strain-dependent genome context variation. Microbiology 150:3547–3560

    Article  CAS  Google Scholar 

  8. Williamnson NR, Fineran PC, Gristwood T, Chawrai SR, Leeper FJ, Salmond GP (2007) Anticancer and immunosuppressive properties of bacterial prodiginines. Future Microbiol 2:605–618

    Article  Google Scholar 

  9. Kim D, Kim JF, Yim JH, Kwon SK, Lee CH, Lee HK (2008) Red to red-the marine bacterium Hahella chejuensis and its product prodigiosin for mitigation of harmful algal blooms. J Microbiol Biotechnol 18:1621–1629

    PubMed  CAS  Google Scholar 

  10. Elahian F, Moghimi B, Dinmohammadi F, Ghamghami M, Hamidi M, Mirzaei SA (2013) The anticâncer gente Prodigiosin is not a multidrug resistance protein substrate. DNA Cell Biol 32:90–97

    Article  CAS  Google Scholar 

  11. Montaner B, Pérez-Tomáz R (2003) The prodigiosins: a new family of anticancer drugs. Curr Cancer Drug Tergets. 3:57–65

    Article  CAS  Google Scholar 

  12. Pérez-Tomáz Ricardo et al (2003) The prodigiosins, proapoptotic drugs with anticancer properties. Biochem Pharmacol 66:1447–1452

    Article  CAS  Google Scholar 

  13. Francisco R, Pérez-Tomás R, Gimènez-Bonafé P, Soto-Cerrato V, Giménez-Xavier P, Ambrosio S (2007) Mechanisms of prodigiosin cytotoxicity in human neuroblastoma cell lines. Eur J Pharmacol 572:111–119

    Article  CAS  Google Scholar 

  14. Mo SJ, Kim BS, Reynolds KA (2005) Production of branched-chain alkylprodiginines in streptomyces coelicolor by replacement of the 3-ketoacyl ACP synthase III initiation enzyme, RedP. Chem Biol 12:191–200

    Article  CAS  Google Scholar 

  15. Wasserman HH, Shaw CK, Sykes RJ (1974) The biosynthesis of metacycloprodigiosin and undecyl prodigiosin. Tetrahedron Lett 33:2787–2790

    Article  Google Scholar 

  16. de Oliveira Santos M (2018) Estimativa 2018: incidência de câncer no Brasil. Rev Bras Cancerol 64:119–120

    Google Scholar 

  17. Vendruscolo F, Tosin I, Giachini AJ, Schmidell W, Ninow JL (2014) Antimicrobial activity of M onascus pigments produced in submerged fermentation. J Food Process Preserv 38:1860–1865

    Article  CAS  Google Scholar 

  18. Nakashima T, Myiazaki Y, Matsuyam Y, Muraoka W, Yamaguchi K, Oda T (2006) Producing mechanism of an algicidal compound against red tide phytoplankton in a marine bacterium γ-proteobacterium. Appl Microbiol Biotechnol 73:684–690

    Article  CAS  Google Scholar 

  19. Lapenda JC et al (2015) Antimicrobial activity of prodigiosin isolated from Serratia marcescens UFPEDA 398. World J Microbiol Biotechnol 31:399–406

    Article  CAS  Google Scholar 

  20. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival. J Immunol Methods 65:55–63

    Article  CAS  Google Scholar 

  21. Alley E, Green R, Schuchter L (2002) Cutaneous toxicities of cancer therapy. Curr Opin Oncol 14:212–216

    Article  CAS  Google Scholar 

  22. Koopman G et al (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415–1420

    Article  CAS  Google Scholar 

  23. Bellosillo B, Villamor N, López-Guillermo A, Marcé S, Esteve J, Campo E, Ontserrat E (2001) Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species. Blood 98:2771–2777

    Article  CAS  Google Scholar 

  24. Andreyeva IN, Gorodnikova TI (2015) Pigmentation of Serratia marcescens and spectral properties of prodigiosin. Microbiology 84:28–33

    Article  CAS  Google Scholar 

  25. Isaka M, Jaturapat A, Kramyu J, Tanticharoen M, Thebtaranonth Y (2002) Potent in vitro antimalarial activity of metacycloprodigiosin isolated from Streptomyces spectabilis BCC 4785. Antimicrob Agents Chemother 46:1112–1113

    Article  CAS  Google Scholar 

  26. Da Silva GP, Mack M, Contiero J (2009) Glycerol: a promising and abundant carbon source for industrial microbiology. Biotechnol Adv 27:30–39

    Article  CAS  Google Scholar 

  27. Asano S et al (1999) Prodigiosin produced by Serratia marcescens enhances the insecticidal activity of Bacillus thuringiensis delta-endotoxin (Cry1C) against common cutworm,Spodoptera litura. Nippon Noyaku Gakkaishi 24:381–385

    CAS  Google Scholar 

  28. Parani K et al (2008) Optimization of prodigiosin production from a strain of Serratia marcescens SR1 and screening for antifungal activity. J Biol Control 22:73–79

    Google Scholar 

  29. Ho TF, Peng YT, Chuang SM, Lin SC, Feng BL, Lu CH, Yu WJ, Chang JS, Chang CC (2009) Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in humanbreast carcinoma cell lines. Toxicol Appl Pharmacol 235:253–260

    Article  CAS  Google Scholar 

  30. Manderville RA (2001) Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products. Curr Med Chem Anti Cancer Agents 1:195–218

    Article  CAS  Google Scholar 

  31. Liu R et al (2005) Potent in vitro anticancer activity of metacycloprodigiosin and undecylprodigiosin from a sponge-derived actinomycete Sac-charopolyspora sp. nov. Arch Pharm Res 28:1341–1344

    Article  CAS  Google Scholar 

  32. Montaner B et al (2000) Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines. Br J Pharmacol 131:585–593

    Article  CAS  Google Scholar 

  33. Pandey R, Chander R, Sainis KB (2009) Prodigiosins as anti cancer agents: living up to their name. Curr Pharm Des 15:732–741

    Article  CAS  Google Scholar 

  34. Chang CC, Wang YH, Chern CM, Liou KT, Hou YC, Peng YT, Shen YC (2011) Prodigiosin inhibits gp91 and iNOS expression to protect mice against the oxidative/nitrosative brain injury induced by hypoxia–ischemia. Toxicol Appl Pharmacol 257:137–147

    Article  CAS  Google Scholar 

  35. Lu CH, Lin SC, Yang SY, Pan MY, Lin YW, Hsu CY, Wei YH, Chang JS, Chang CC (2012) Prodigiosin-induced cytotoxicity involves RAD51 down-regulation through the JNK and p38 MAPK pathways in human breast carcinoma cell lines. Toxicol Lett 212:83–89

    Article  CAS  Google Scholar 

  36. Silva Júnior END, de Moura MAB, Pinto AV, Pinto MDCF, de Souza MCB, Araújo AJ, Goulart MO (2009) Cytotoxic, trypanocidal activities and physicochemical parameters of nor-2-lapachone-based 1, 2, 3-triazoles. J Braz Chem Soc 20:635–643

    Article  Google Scholar 

  37. Hsieh HY, Shieh JJ, Chen CJ, Pan MY, Yang SY, Lin SC, Chang CC (2012) Prodigiosin down-regulates SKP2 to induce p27KIP1 stabilization and antiproliferation in human lung adenocarcinoma cells. Br J Pharmacol 166:2095–2108

    Article  CAS  Google Scholar 

  38. Lorenzo Y, Azqueta A, Luna L, Bonilla F, Domínguez G, Collins AR (2009) The carotenoid β-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells. Carcinogenesis 30:308–314

    Article  CAS  Google Scholar 

  39. Lins JCL, De Melo MEB, Do Nascimento SC, Adam ML (2015) Differential genomic damage in different tumor lines induced by prodigiosin. Anticancer Res 35:3325–3332

    PubMed  CAS  Google Scholar 

  40. Lapenda JCL et al (2019) Evidence of genomic damage induced by prodigiosin produced by Serratia marcenscens UFPEDA 395 in human peripheral blood mononuclear cells. Biomed J Sci Tech Res 13:10039–10046

    Google Scholar 

Download references

Acknowledgements

The authors thank the responsible technical team, the Federal University of Pernambuco for the physical and structural support, giving their laboratories to perform the tests and the fundamentally important funding agencies such as CNPq and CAPES.

Author information

Authors and Affiliations

  1. Department of Antibiotics, Federal University of Pernambuco, Recife, PE, Brazil

    J. C. L. Lapenda, M. D. Rodrigues & S. C. Nascimento

  2. Immunology Laboratory, Aggeu Magalhães Research Center, Recife, PE, Brazil

    V. P. Alves

  3. Department of Biological Sciences, Federal University of Pernambuco, Academic Center of Vitória, Recife, PE, Brazil

    M. L. Adam

Authors
  1. J. C. L. Lapenda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. P. Alves
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. L. Adam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. D. Rodrigues
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. C. Nascimento
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. C. L. Lapenda.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lapenda, J.C.L., Alves, V.P., Adam, M.L. et al. Cytotoxic Effect of Prodigiosin, Natural Red Pigment, Isolated from Serratia marcescens UFPEDA 398. Indian J Microbiol 60, 182–195 (2020). https://doi.org/10.1007/s12088-020-00859-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12088-020-00859-6

Keywords

Search

Navigation